180 related articles for article (PubMed ID: 23236390)
1. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-specific collagen type IV-α
Funk SD; Bayer RH; Miner JH
Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
[TBL] [Abstract][Full Text] [Related]
3. Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.
Madison J; Wilhelm K; Meehan DT; Gratton MA; Vosik D; Samuelson G; Ott M; Fascianella J; Nelson N; Cosgrove D
J Pathol; 2024 Mar; 262(3):296-309. PubMed ID: 38129319
[TBL] [Abstract][Full Text] [Related]
4. Role of the podocyte (and glomerular endothelium) in building the GBM.
Abrahamson DR
Semin Nephrol; 2012 Jul; 32(4):342-9. PubMed ID: 22958488
[TBL] [Abstract][Full Text] [Related]
5. Genetic reprogramming with stem cells regenerates glomerular epithelial podocytes in Alport syndrome.
LeBleu VS; Kanasaki K; Lovisa S; Alge JL; Kim J; Chen Y; Teng Y; Gerami-Naini B; Sugimoto H; Kato N; Revuelta I; Grau N; Sleeman JP; Taduri G; Kizu A; Rafii S; Hochedlinger K; Quaggin SE; Kalluri R
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38561223
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.
Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC
Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213
[TBL] [Abstract][Full Text] [Related]
7. Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
Ding F; Wickman L; Wang SQ; Zhang Y; Wang F; Afshinnia F; Hodgin J; Ding J; Wiggins RC
Kidney Int; 2017 Dec; 92(6):1515-1525. PubMed ID: 28754557
[TBL] [Abstract][Full Text] [Related]
8. Digenic Alport Syndrome.
Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of glomerular basement membrane collagen IV α chains in paraffin sections from patients with focal segmental glomerulosclerosis and Alport gene variants.
Puapatanakul P; Isaranuwatchai S; Chanakul A; Surintrspanont J; Iampenkhae K; Kanjanabuch T; Suphapeetiporn K; Charu V; Suleiman HY; Praditpornsilpa K; Miner JH
Kidney Int; 2024 May; 105(5):1049-1057. PubMed ID: 38401706
[TBL] [Abstract][Full Text] [Related]
10. Collagen IV of basement membranes: II. Emergence of collagen IV
Pokidysheva EN; Redhair N; Ailsworth O; Page-McCaw P; Rollins-Smith L; Jamwal VS; Ohta Y; Bächinger HP; Murawala P; Flajnik M; Fogo AB; Abrahamson D; Hudson JK; Boudko SP; Hudson BG
J Biol Chem; 2023 Dec; 299(12):105459. PubMed ID: 37977222
[TBL] [Abstract][Full Text] [Related]
11. RNA-seq analysis of gene expression profiles in isolated stria vascularis from wild-type and Alport mice reveals key pathways underling Alport strial pathogenesis.
Dufek B; Meehan DT; Delimont D; Wilhelm K; Samuelson G; Coenen R; Madison J; Doyle E; Smyth B; Phillips G; Gratton MA; Cosgrove D
PLoS One; 2020; 15(8):e0237907. PubMed ID: 32822386
[TBL] [Abstract][Full Text] [Related]
12. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A
Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568
[TBL] [Abstract][Full Text] [Related]
13. Alport syndrome and Pierson syndrome: Diseases of the glomerular basement membrane.
Funk SD; Lin MH; Miner JH
Matrix Biol; 2018 Oct; 71-72():250-261. PubMed ID: 29673759
[TBL] [Abstract][Full Text] [Related]
14. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.
Hirayama R; Toyohara K; Watanabe K; Otsuki T; Araoka T; Mae SI; Horinouchi T; Yamamura T; Okita K; Hotta A; Iijima K; Nozu K; Osafune K
Commun Biol; 2023 Sep; 6(1):854. PubMed ID: 37770589
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for Genetic Testing and Management of Alport Syndrome.
Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
[TBL] [Abstract][Full Text] [Related]
16. Glomerular basement membrane and related glomerular disease.
Chen YM; Miner JH
Transl Res; 2012 Oct; 160(4):291-7. PubMed ID: 22683419
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.
Yuan X; Su Q; Wang H; Shi S; Liu L; Lv J; Wang S; Zhu L; Zhang H
J Am Soc Nephrol; 2023 Jan; 34(1):132-144. PubMed ID: 36130833
[TBL] [Abstract][Full Text] [Related]
18. X-linked Alport syndrome presenting in mother and son with the same unique histopathological features.
Bergeron NAD; Garneau AP; Rousseau-Gagnon M; Riopel J; Isenring P
J Nephrol; 2024 Apr; 37(3):769-772. PubMed ID: 38668984
[TBL] [Abstract][Full Text] [Related]
19. Glomerular filtration and podocyte tensional homeostasis: importance of the minor type IV collagen network.
Bersie-Larson LM; Gyoneva L; Goodman DJ; Dorfman KD; Segal Y; Barocas VH
Biomech Model Mechanobiol; 2020 Dec; 19(6):2433-2442. PubMed ID: 32462439
[TBL] [Abstract][Full Text] [Related]
20. Laminin-521 Protein Therapy for Glomerular Basement Membrane and Podocyte Abnormalities in a Model of Pierson Syndrome.
Lin MH; Miller JB; Kikkawa Y; Suleiman HY; Tryggvason K; Hodges BL; Miner JH
J Am Soc Nephrol; 2018 May; 29(5):1426-1436. PubMed ID: 29472414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
